<DOC>
	<DOCNO>NCT02931981</DOCNO>
	<brief_summary>Our study aim evaluate role Dickkopf-4 biomarkers treatment gastrointestinal stromal tumor .</brief_summary>
	<brief_title>Serum Dickkopf-4 Biomarker Diagnosis Treatment Gastrointestinal Stromal Tumor</brief_title>
	<detailed_description>To identify whether Dickkopf-4 ( DKK4 ) could potential biomarker diagnosis prognosis patient gastrointestinal stromal tumor ( GIST ) . Serum collect 50 patient GIST . Serological level DKK4 examine enzyme-linked immunosorbent assay ( ELISA ) . The sensitivity specificity compare modify NIH risk criterion . A 3-year follow-up monitor evaluate correlation DKK4 serum level relapse-free overall survival . The expression DKK4 GIST tumor tissue also evaluate use immunohistochemistry staining .</detailed_description>
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<criteria>Primary gastrointestinal stromal tumor confirm pathologically surgery biopsy Age 18 70 year No serious organic mental illness ; Pregnancy No pathologic result Suffering malignancy time .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>DKK4</keyword>
	<keyword>Gastrointestinal Stromal Tumor</keyword>
	<keyword>Biomarker</keyword>
</DOC>